Cargando…
Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients
SIMPLE SUMMARY: Hypolipidemic drugs are among the most frequently prescribed medications in the Western world. Since many studies have indicated their role in carcinogenesis, this work aimed to investigate their association with the occurrence of a second primary malignancy in colorectal cancer surv...
Autores principales: | Halámková, Jana, Bohovicová, Lucia, Pehalová, Lucie, Goněc, Roman, Staněk, Teodor, Kazda, Tomáš, Mouková, Lucie, Krákorová, Dagmar Adámková, Kozáková, Šárka, Svoboda, Marek, Demlová, Regina, Kiss, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997159/ https://www.ncbi.nlm.nih.gov/pubmed/35406471 http://dx.doi.org/10.3390/cancers14071699 |
Ejemplares similares
-
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
por: Halámková, Jana, et al.
Publicado: (2023) -
Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021) -
The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021) -
Everolimus-related unilateral abdominal lymphedema in a renal cancer patient: A case report
por: Halamkova, Jana, et al.
Publicado: (2020) -
Penis as a primary site of an extraskeletal Ewing sarcoma: A case report
por: Krakorova, Dagmar Adamkova, et al.
Publicado: (2021)